Senseonics Suspends Commercial US Sales of Eversense in Response to COVID-19
On March 26, Senseonics suspended all commercial sales of the Eversense continuous glucose monitor (CGM) in the United States.
The Diabetes Disaster Response Coalition Coronavirus Response
On March 12, the Diabetes Disaster Response Coalition (DDRC) circulated an update to coalition members in response to coronavirus (COVID-19). Here are the steps the organization is taking and other important information to note.
ADA 2019 – American Diabetes Association’s 79th Annual Conference
The Beyond Type 2 team's live coverage of the American Diabetes Association's 79th Annual Conference.
New Medicare Plan Will Cap Insulin Copays at $35
Today, the Centers for Medicare & Medicaid Services (CMS) launched a new plan for some Medicare Part D participants to pay a maximum $35 copay for their monthly supply of insulin.
FDA Approves Triple Combination Pill Trijardy for T2D
On January 27, 2020, the U.S. Food and Drug Administration (FDA) approved Trijardy XR, a triple combination drug of empagliflozin (Jardiance), linagliptin (Tradjenta), and metformin. This is the first triple combination drug available for people with Type 2 diabetes.
Coronavirus and Diabetes – What You Should Know
A helpful breakdown of what people with diabetes should know about the Coronavirus that's been making headlines since first reports of it emerged in China earlier this year.
Omnipod Closed Loop Technology to be Compatible with Both Abbott and Dexcom CGMs
Abbott and Dexcom announced formal partnerships with Insulet to be compatible as CGMs on the Omnipod Horizon Automated Insulin Delivery System.
AADE Rebrands, Changes Name to ADCES
On January 22, 2020, the organization formerly known as the American Association of Diabetes Educators (AADE) announced a change to the organization's name to the Association of Diabetes Care and Education Specialists (ADCES) as part of a large rebrand. The change represents a shift in the organization from the specialty "diabetes educator" to a comprehensive "diabetes care and education specialist" to encompass the range of expertise among specialists who work with people with diabetes.
Beyond Type 2 Celebrates One Year Anniversary, Adds New Partner
Today, global diabetes non-profit Beyond Type 1 celebrates the one year anniversary of the launch of Beyond Type 2 - a platform and community serving those impacted by Type 2 diabetes. In 2020, Beyond Type 2 will be supported by many of its original Founding Partners and gains support from new partner Insulet.
